Published in Cardiovasc Diabetol on September 16, 2017
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation (1989) 9.97
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology (1991) 7.27
Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia (2001) 4.22
Circulating osteoblast-lineage cells in humans. N Engl J Med (2005) 4.19
High-density lipoprotein as a therapeutic target: a systematic review. JAMA (2007) 3.92
Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res (2002) 3.23
Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes (2010) 2.94
Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol (2005) 2.61
Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care (2011) 2.00
High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol (2004) 2.00
Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol (2003) 1.76
The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis (2011) 1.62
Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol (2008) 1.55
Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control. Arch Intern Med (2000) 1.53
Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab (2013) 1.51
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care (2014) 1.47
Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb (1991) 1.46
Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study. Diabetes Care (2007) 1.46
Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ Res (2011) 1.41
Expression of human bone-related proteins in the hematopoietic microenvironment. J Clin Invest (1990) 1.38
Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun (2007) 1.32
The role of osteocalcin in human glucose metabolism: marker or mediator? Nat Rev Endocrinol (2012) 1.31
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care (2008) 1.27
Interstitial fluid lipoproteins. J Lipid Res (1987) 1.23
Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporos Int (2011) 1.18
Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol (2008) 1.14
SR-BI-mediated high density lipoprotein (HDL) endocytosis leads to HDL resecretion facilitating cholesterol efflux. J Biol Chem (2006) 1.12
Circulating osteogenic cells: implications for injury, repair, and regeneration. J Bone Miner Res (2011) 1.11
Emerging role of circulating calcifying cells in the bone-vascular axis. Circulation (2012) 1.11
A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications. Diabetologia (2013) 0.97
Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol (2013) 0.94
Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. Exp Diabetes Res (2012) 0.93
Oxidized low-density lipoprotein promotes osteoblast differentiation in primary cultures of vascular smooth muscle cells by up-regulating Osterix expression in an Msx2-dependent manner. J Cell Biochem (2011) 0.93
Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. Int J Biochem Cell Biol (2005) 0.92
Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis. Eur Heart J (2012) 0.92
Decorin GAG synthesis and TGF-β signaling mediate Ox-LDL-induced mineralization of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2011) 0.91
HDL endocytosis and resecretion. Biochim Biophys Acta (2013) 0.90
Oxidized low-density lipoprotein and β-glycerophosphate synergistically induce endothelial progenitor cell ossification. Acta Pharmacol Sin (2011) 0.87
Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes. Diabetes Care (2014) 0.85
Circulating myeloid calcifying cells have antiangiogenic activity via thrombospondin-1 overexpression. FASEB J (2013) 0.84
Osteogenic monocytes within the coronary circulation and their association with plaque vulnerability in patients with early atherosclerosis. Int J Cardiol (2014) 0.83
Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes. J Endocrinol Invest (2014) 0.81
Platelets express and release osteocalcin and co-localize in human calcified atherosclerotic plaques. J Thromb Haemost (2013) 0.78
Myeloid calcifying cells promote atherosclerotic calcification via paracrine activity and allograft inflammatory factor-1 overexpression. Basic Res Cardiol (2013) 0.78
Relationship between serum osteocalcin level and carotid intima-media thickness in a metabolically healthy Chinese population. Cardiovasc Diabetol (2015) 0.77
The macrophage and its related cholesterol efflux as a HDL function index in atherosclerosis. Clin Chim Acta (2016) 0.76
Effects of lipid-lowering drugs on high-density lipoprotein subclasses in healthy men-a randomized trial. PLoS One (2014) 0.76
Cardiovascular disease protection in long-duration type 1 diabetes and sex differences. Diabetes Care (2015) 0.76
Bone health in subjects with type 1 diabetes for more than 50 years. Acta Diabetol (2017) 0.75
Bone Microarchitecture in Type 1 Diabetes: It Is Complicated. Curr Osteoporos Rep (2016) 0.76
Bone health in subjects with type 1 diabetes for more than 50 years. Acta Diabetol (2017) 0.75